VVT Medical

Varicose Vein Treatment

Health Tech & Life Sciences
Public on TSXV on Jul 2025
Public Kefar Sava, Israel Founded 2007
Last updated 2026-06-18
Total raised
$2.6M
Last: 2026-03
Stage
Public
Founded
2007
Headcount
21
HQ
Kefar Sava, Israel
Sector
Health Tech & Life Sciences

About

VVT Medical specializes in the research, development, manufacturing and commercialization of minimally invasive, non-thermal non-tumescent- NT-NT solutions for the treatment of varicose veins.

VVT Medical’s advanced, proprietary solutions combine best practices in vein treatment with a powerful, patented delivery system to provide a simpler, more effective approach to treatment. Its flagship ScleroSafe platform enables physicians to perform quick, office-based procedures without the need for tumescent anesthesia or costly capital equipment. VVT Medical’s solutions can be performed in a range of outpatient settings including vein clinics, day care clinics, angio suites, catheterization laboratories and hospitals.

ScleroSafe with V-Block is especially designed to simply, safely and effectively treat severely dilated and challenging Great Saphenous Vein (GSV) conditions, including GSV valve incompetence and Reflux.

Funding history · 2 rounds · $2.6M total

2026-03
$1.1M
2025-07

Q&A

What is VVT Medical's primary focus?
VVT Medical specializes in the research, development, manufacturing, and commercialization of minimally invasive, non-thermal, non-tumescent solutions for treating varicose veins.
When did VVT Medical go public and on which exchange?
VVT Medical went public on the TSX Venture Exchange (TSXV) in July 2025.
What is the name of VVT Medical's flagship product?
VVT Medical's flagship product is the ScleroSafe platform, which includes ScleroSafe with V-Block.
How many employees does VVT Medical have?
VVT Medical has 11-50 employees.
What was VVT Medical's most recent funding round?
VVT Medical's most recent funding round was in March 2026, raising $1.1 million USD.
Which investor participated in VVT Medical's July 2025 funding round?
I3 Capital Group participated in VVT Medical's funding round in July 2025.
Has VVT Medical expanded its commercial footprint in Europe recently?
Yes, in June 2026, VVT Med expanded its European commercial footprint through an exclusive distribution agreement in Greece.
Has VVT Medical expanded into the Dominican Republic?
Yes, in June 2026, VVT Med expanded into the Dominican Republic by appointing Antilles Medical as its exclusive distributor.
Did VVT Medical announce a significant distribution deal in India?
Yes, in November 2025, VVT Med signed a $3.7 million distribution deal for India.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

medical-devicescatheterstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)